Rhino Max supplement recalled

March 26, 2007

Cosmos Trading and the FDA have notified consumers and healthcare professionals of a voluntary recall of a supplement sold under the name Rhino Max (Rhino V Max) in 5-tablet or 15-tablet boxes. FDA lab analysis of product samples found that it contains aminotadalafil, an analog of tadalafil (Cialis, Lilly ICOS), an FDA-approved drug use to treat erectile dysfunction.

Cosmos Trading and the FDA have notified consumers and healthcare professionals of a voluntary recall of a supplement sold under the name Rhino Max (Rhino V Max) in 5-tablet or 15-tablet boxes. FDA lab analysis of product samples found that it contains aminotadalafil, an analog of tadalafil (Cialis, Lilly ICOS), an FDA-approved drug use to treat erectile dysfunction. The agency advised that this poses a threat to consumers because aminotadalafil may interact with nitrates found in some prescription drugs much as nitroglycerin and may lower blood pressure to dangerous levels. Patients who have diabetes, high blood pressure, high cholesterol, or heart disease often take nitrates. Consumers who have Rhino Max in their possession should stop using it immediately and contact their physician if they experience any problem that may be related to taking this product. For more information, call (213) 598-6699. To report adverse events, visit